Compare
Align Technology vs West Pharmaceutical Services (ALGN vs WST)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Align Technology (ALGN) returned +21.0% and West Pharmaceutical Services (WST) +41.0%; so far this year the figures are +6.3% and +45.3%.
West Pharmaceutical Services is the larger company by market value, about 2.4 times the size of Align Technology.
On trailing earnings, ALGN trades at 24.2 times and WST at 44.9 times.
Revenue grew +4.4% at ALGN and +12.6% at WST over the last year.
ALGN pays no dividend. WST yields 0.22%.
Data as of the latest close. Not investment advice.
Relative performance
| ALGN | WST | |
|---|---|---|
| Price | $166.00 | $399.81 |
| 1-day | +4.16% | +1.87% |
| YTD | +6.31% | +45.31% |
| 1 year | +20.98% | +41.01% |
| 3 years | -9.39% | +24.29% |
| Market cap | $11.7B | $27.9B |
| P/E | 24.2 | 44.9 |
| P/S | 2.81 | 8.20 |
| P/B | 2.72 | 9.38 |
| Revenue growth | +4.40% | +12.60% |
| EPS growth | +32.90% | +32.00% |
| Gross margin % | 69.1 | 37.6 |
| Net margin % | 11.8 | 18.8 |
| ROE % | 11.4 | 21.5 |
| Debt / equity | 0.00 | 0.07 |
| FCF yield % | 5.1 | 1.6 |
| Dividend yield % | — | 0.22 |
| Beta | 1.32 | 0.66 |
| RSI (14) | 64.7 | 57.5 |
| Technical rating |